CGC Stock Analysis: Buy, Sell, or Hold?
CGC - Canopy Growth Corporation Common Shares
$1.00
0.05 (5.41%)
▲
5d:
+9.52%
30d:
-5.66%
90d:
+2.63%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 14, 2026
Get Alerted When CGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CGC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CGC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CGC is currently trading at $1.00, which is considered fair relative to its 30-day fair value range of $0.95 to $1.06. From a valuation perspective, the stock is trading at a discount (Forward PE: -3.9) compared to its historical average (13.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CGC is showing sideways momentum. Immediate support is located at $0.91, while resistance sits at $1.06. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: CGC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1.22 (+22.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CGC is showing sideways momentum. Immediate support is located at $0.91, while resistance sits at $1.06. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: CGC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1.22 (+22.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.95 -
$1.06
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.9%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 22.1% below Wall St target ($1.22)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$0.95 -
$1.06
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.91
Resistance Level
$1.06
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.91
Wall Street Target
$1.22
(+22.1%)
Revenue Growth (YoY)
9.6%
Profit Margin
-92.4%
PE vs Historical
-3.9 vs 13.0
CHEAP
Share & Embed Analysis
Last updated: July 03, 2026 3:25 PM ET
Data refreshes hourly during market hours. Next update: 4:25 PM
Data refreshes hourly during market hours. Next update: 4:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph Bayern
SELL
2658 shares
2026-03-31
M Shan Atkins
SELL
2074 shares
2026-03-31
Theresa Yanofsky
SELL
10373 shares
2026-03-31
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
Advanced CGC Option Strategies
Professional options setups generated by AI based on today's CGC price and gamma walls.
